Merit Medical Systems, Inc. (MMSI)

US — Healthcare Sector

Peers: TFX COO WST ICUI ANGO ATR HAE NVST XRAY ALC RMD

Automate Your Wheel Strategy on MMSI

With Tiblio's Option Bot, you can configure your own wheel strategy including MMSI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

symbol MMSI
Rev/Share 24.2275
Book/Share 25.1614
PB 3.3078
Debt/Equity 0.5514
CurrentRatio 4.0921
ROIC 0.0538

MktCap 4928807108.0
FreeCF/Share 3.818
PFCF 21.8284
PE 41.3219
Debt/Assets 0.3173
DivYield 0
ROE 0.0848

Rating B
Score 3
Recommendation Neutral
P/E Score 1
DCF Score 4
P/B Score 2
D/E Score 2

Recent Analyst Ratings

Type	Ticker	Analyst Firm	Previous Rating	Current Rating	Previous Price Target	Current Price Target	Date
Initiation	MMSI	JP Morgan	--	Overweight	--	$120	March 28, 2025
Upgrade	MMSI	Wells Fargo	Equal Weight	Overweight	$103	$120	Dec. 11, 2024

News

Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership

MMSI
Published: March 18, 2025 by: GlobeNewsWire
Sentiment: Neutral

SOUTH JORDAN, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced that Chairman and Chief Executive Officer, Fred Lampropoulos, will visit the Nasdaq MarketSite in Times Square to ring the opening bell on Wednesday, March 19, 2025. The ceremony begins at 9:15 A.M. (EDT) and the bell ringing takes place at 9:30 A.M.

image for news Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership

First Patient Enrolled in Merit Medical's PREEMIE Study

MMSI
Published: March 10, 2025 by: GlobeNewsWire
Sentiment: Neutral

Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants

image for news First Patient Enrolled in Merit Medical's PREEMIE Study

Compared to Estimates, Merit Medical (MMSI) Q4 Earnings: A Look at Key Metrics

MMSI
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Neutral

While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

image for news Compared to Estimates, Merit Medical (MMSI) Q4 Earnings: A Look at Key Metrics

Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates

MMSI
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive

Merit Medical (MMSI) came out with quarterly earnings of $0.93 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.81 per share a year ago.

image for news Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates

Here is Why Growth Investors Should Buy Merit Medical (MMSI) Now

MMSI
Published: February 21, 2025 by: Zacks Investment Research
Sentiment: Positive

Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.

image for news Here is Why Growth Investors Should Buy Merit Medical (MMSI) Now

1
2 (current)

About Merit Medical Systems, Inc. (MMSI)

IPO Date 1990-05-14
Website https://www.merit.com
Industry Medical - Instruments & Supplies
CEO Fred P. Lampropoulos
Employees 7400

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.